Ideaya Biosciences Inc
IDYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.38B
Close$
$-1.63
104.4% downside
Current Fair Value
104.4% downsideOvervalued by 104.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.38 Billion |
|---|---|
| Enterprise Value | $3.25 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | -0.09 |
| Outstanding Shares | 88,699,754 |
Return
| Return on Equity | -14.94% |
|---|---|
| Return on Assets | -13.59% |
| Return on Invested Capital | -19.12% |
Valuation & Multiples
| P/E Ratio | -22.47 |
|---|---|
| PEG | -59.13 |
| Price to Sales | 18.51 |
| Price to Book Ratio | 3.7 |
| Enterprise Value to Revenue | 14.41 |
| Enterprise Value to EBIT | -17.59 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
$8.02 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
$8.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 78.51% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.43%▼ 103.44% |
|---|---|
| Total Invested | $112.35M▼ 96.45% |
| Investors Holding | 53▼ 213.00% |
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata